Yongzheng Hu

Mr. Yongzheng Hu

The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2023 in PeerJ
Verified
Journal Article
Open access
PDF file
YHYongzheng Hu
Yongzheng Hu
YYYani Yu
Yani Yu
HDHui Dong
Hui Dong
WJWei Jiang
Wei Jiang
Background: Diabetic nephropathy (DN), the most intractable complication in diabetes patients, can lead to proteinuria and progressive reduction of glomerular filtration rate (GFR), which seriously affects the quality of life of patients and is associated with high mortality. However, the lack of accurate key candidate genes makes diagnosis of DN very difficult. This study aimed to identify new potential candidate genes for DN using bioinformatics, and elucidated the mechanism of DN at the cellular transcriptional level. Methods: The microarray dataset GSE30529 was downloaded from the Gene Expression Omnibus Database (GEO), and the differentially expressed genes (DEGs) were screened by R software. We used Gene Ontology (GO), gene set enrichment analysis (GSEA), and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis to identify the signal pathways and genes. Protein-protein interaction (PPI) networks were constructed using the STRING database. The GSE30122 dataset was selected as the validation set. Receiver operating characteristic (ROC) curves were applied to evaluate the predictive value of genes. An area under curve (AUC) greater than 0.85 was considered to be of high diagnostic value. Several online databases were used to predict miRNAs and transcription factors (TFs) capable of binding hub genes. Cytoscape was used for constructing a miRNA-mRNA-TF network. The online database ‘nephroseq’ predicted the correlation between genes and kidney function. The serum level of creatinine, BUN, and albumin, and the urinary protein/creatinine ratio of the DN rat model were detected. The expression of hub genes was further verified through qPCR. Data were analyzed statistically using Student’s t-test by the ‘ggpubr’ package. Results: A total of 463 DEGs were identified from GSE30529. According to enrichment analysis, DEGs were mainly enriched in the immune response, coagulation cascades, and cytokine signaling pathways. Twenty hub genes with the highest connectivity and several gene cluster modules were ensured using Cytoscape. Five high diagnostic hub genes were selected and verified by GSE30122. The MiRNA-mRNA-TF network suggested a potential RNA regulatory relationship. Hub gene expression was positively correlated with kidney injury. The level of serum creatinine and BUN in the DN group was higher than in the control group (unpaired t test, t = 3.391, df = 4, p = 0.0275, r = 0.861). Meanwhile, the DN group had a higher urinary protein/creatinine ratio (unpaired t test, t = 17.23, df = 16, p < 0.001, r = 0.974). QPCR results showed that the potential candidate genes for DN diagnosis included C1QB, ITGAM, and ITGB2. Conclusions: We identified C1QB, ITGAM and ITGB2 as potential candidate genes for DN diagnosis and therapy and provided insight into the mechanisms of DN development at transcriptome level. We further completed the construction of miRNA-mRNA-TF network to propose potential RNA regulatory pathways adjusting disease progression in DN.

2 January 2026 in Virus Research
Verified
Journal Article
Open access
YHYongzheng Hu
Yongzheng Hu
XQXinyue Qi
Xinyue Qi
YJYan Jiang
Yan Jiang
WJWei Jiang
Wei Jiang
Background Hepatitis B virus (HBV) remains a leading cause of cirrhosis and hepatocellular carcinoma. Improving outcomes requires effective health-system performance and equitable delivery of prevention and care. Methods Using Global Burden of Disease 1990-2021 estimates for 204 countries/territories, we derived an HBV Quality of Care Index (QCI) from four secondary ratios (mortality-to-incidence, DALYs-to-prevalence, YLL-to-YLD, prevalence-to-incidence) using principal component analysis and rescaled it to 0-100. We assessed temporal trends, sex- and age-specific patterns, Socio-demographic Index (SDI) gradients, and inequality (slope and concentration indices), and generated projections to 2034. Findings Global QCI increased modestly since 1990, but substantial cross-national heterogeneity persisted and widened. High-SDI settings generally achieved the highest QCI with narrowing female-male differences, whereas many low and lower-middle SDI countries stagnated or declined. QCI was consistently lower at older ages, consistent with late presentation and constrained advanced care. Projections suggest incremental gains approaching a plateau by the early 2030s, with persistent dispersion between countries through 2034. Interpretation HBV care quality is improving but not equitably. Accelerating progress will require integrated, One Health-oriented actions: sustaining timely infant vaccination (including birth dose) and prevention of mother-to-child transmission, expanding decentralized testing with reliable linkage to affordable antiviral therapy, and strengthening primary care, supply chains, and data systems to target under-performing populations. These measures provide a pragmatic path to narrowing QCI gaps and advancing the 2030 elimination targets.